Neurosearch to Sell Huntexil Drug to Israel's Teva

27.09.2012 - Danish biopharma company Neurosearch said on Thursday it had signed a 149 million Danish crowns ($25.7 million) deal with Israel's Teva Pharmaceutical Industries for the sale of...